Search

Author/Creator Hanusch, C.

1. 1801 Neoadjuvant chemotherapy with trastuzumab or lapatinib: Survival analysis of the HER2-positive cohort of the GeparQuinto study (GBG 44). (September 2015)

Authors:
Untch, M.; Von Minckwitz, G.; Gerber, B.; Eidtmann, H.; Rezai, M.; Fasching, P.A.; Tesch, H.; Eggemann, H.; Schrader, I.; Kittel, K.; Hanusch, C.; Huober, J.; Solbach, C.; Jackisch, C.; Kunz, G.; Blohmer, J.; Hauschild, M.; Fehm, T.; Nekljudova, V.; Loibl, S.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S264
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Zoledronate for patients with invasive residual disease after anthracyclines-taxane-based chemotherapy for early breast cancer – The Phase III NeoAdjuvant Trial Add-oN (NaTaN) study (GBG 36/ABCSG 29). (September 2016)

Authors:
von Minckwitz, G.; Rezai, M.; Tesch, H.; Huober, J.; Gerber, B.; Zahm, D.M.; Hilfrich, J.; Costa, S.D.; Dubsky, P.; Blohmer, J.U.; Denkert, C.; Hanusch, C.; Jackisch, C.; Kümmel, S.; Fasching, P.A.; Schneeweiss, A.; Paepke, S.; Untch, M.; Burchardi, N.; Mehta, K.
Journal:
European journal of cancer
Issue:
Volume 64(2016)
Page Start:
12
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search